RMD ResMed Inc.

Largest Consumer Sleep Study Just Released at CES 2017

At CES 2017, SleepScore Labs shared exciting new information that will change the way people think about their sleep.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170106005646/en/

National sleep survey results (Graphic: Business Wire)

National sleep survey results (Graphic: Business Wire)

The national sleep survey and America’s SleepScore program, launched in October 2016, was developed by ResMed (NYSE: RMD) and “The Dr. Oz Show” to foster better public understanding of sleep health. More than 20,000 individuals have enrolled in the continuing study, which so far has collected more than 1.53 million nights’ of consumer sleep data.

From the study, SleepScore Labs, a joint venture announced today between ResMed, Dr. Mehmet Oz and Pegasus Capital Advisors, LP, has determined a national SleepScore and begun analyzing the data from the most comprehensive and accurate collection of high quality consumer sleep data on the planet, the landmark national sleep study on SleepScore.com.

During a panel discussion today at the CES Digital Health Summit, “Confronting the Sleep Epidemic Head-On,” Dr. Oz and ResMed will share more insights from the study.

“America didn’t do well at its checkup, with a SleepScore of 77. The good news is we can use America’s SleepScore as a teachable moment and national conversation starter about how to fix our country’s sleep,” said Dr. Mehmet Oz, host of The Dr. Oz Show and co-founder of SleepScore Labs. “With the information we’re sharing today, and the work we’ll be doing through SleepScore Labs, the average person will get easy, actionable information they can start using now to improve their sleep hygiene and their overall health. More Americans should be prioritizing sleep, and thankfully we have more useful tools than ever before.”

“This is the largest objective consumer sleep study ever evaluated, giving us the tools to make a real impact on sleep deprivation,” said Colin Lawlor, CEO of SleepScore Labs. “This historic survey shows how the SleepScore by ResMed™ technology and its capabilities can be used across the $58 billion dollar consumer sleep industry to evaluate the performance of sleep products and services and to improve them, so those products and services can be more helpful to someone’s health. The sheer numbers of people with sleep issues are staggering, but solving the problem has until now been a shot in the dark.”

SleepScore insights include:

  • 79% of the population sleeps less than the 7 hours recommended by the American Academy of Sleep Medicine – Most Americans sleep one hour less. To put this in context, a recent study by AAA reported that sleeping as little as one hour less than recommended doubles the risk of a traffic accident.
  • Women sleep longer than men – Men average 5 hours, 45 minutes, while women average 6 hours, 9 minutes.
  • On average, Americans go to bed at 10:21 pm and wake up at 7:41 am. People in the Pacific time zone go to bed the latest, at 11:17 p.m., and people in the Eastern time zone wake up the earliest at 7:40 a.m.
  • New York vs. Los Angeles – New Yorkers go to bed earlier than Los Angeleans (by just under three minutes).
  • Exercise is good for sleep – Any amount is helpful, but the optimal amount is 30 minutes, which correlates with 14 minutes of extra sleep per night.
  • Caffeine – Three or fewer cups of coffee didn’t notably affect average sleep time, but those who drank four cups or more slept 26 minutes less.
  • Alcohol – Those who had one or two drinks slept an average of 16 minutes more than people who had more than two drinks – or none at all.
  • Children can be both good and bad for sleep – Men with 0-1 children get the most sleep, and women with 2-3 children get the most sleep. Having more children seems to impact men more – they lose 45 minutes of sleep per night with 4 or more children, whereas women with 4 or more children only lose 25 minutes.
  • Mattresses matter –The type of mattress people sleep on appears to make an average difference of 20 minutes sleep per night.
  • Technology makes a difference – First cuts of the data show a clear benefit from the use of at least some smart sleep and wake lighting systems.
  • The S+ works – Poor sleepers that have used the S+ have increased their sleep by 31 minutes per night.
  • Common sleep problems – Excessive fatigue during the day and taking too long to fall asleep were the most common reported issues. Waking up in the middle of the night is also a major problem for many Americans.
  • Sleep aids – 50% of study participants reported using a mix of two or more sleep aids per night, such as prescription medications, over the counter sleeping pills and herbal remedies/food supplements for sleep.
  • The 2016 Election –- Americans lost an average of 25 minutes of quality sleep on November 8, 2016, the night of the presidential election. The SleepScore Survey reported the average SleepScores for November 8 and 9, 2016 were the lowest on record when compared to average SleepScores of 2015 and 2016. The data showed major anomalies and significant changes in sleep times and stress levels on the East and West Coasts and some of the lowest SleepScores recorded since the S+ device was launched in October 2014. 30% of those on the West Coast reported elevated stress levels on election night while 24% of those monitored on the East Coast reported higher stress levels. Both continue to show elevated stress levels – 17% on the East Coast and 10% on the West Coast. None of the data collected explored political affiliation, so it’s not possible to associate elevated levels of stress with any voter groups.

SleepScore Labs will be looking more closely at these and other data in the coming months.

Study Methodology:

Study participants were self-selected and likely participated out of a desire to improve their sleep; that said there is also a sizeable number with good sleep. More than 20,000 participants used the S+, the most accurate and comprehensive consumer sleep technology which objectively measures movement, breathing, light, temperature and assesses sleep stage every 30 seconds during sleep. An additional 22,000 people completed quizzes that explored lifestyle habits providing additional survey data and insight into habits, practices, stress levels, alcohol, exercise and caffeine intake and various nonbiometric factors. A total of 1.53 million nights of sleep data were assessed using the SleepScore by ResMed technology measuring more than 11.1 million hours of sleep and 1.4 billion individual data points which amount to the largest objectively measured consumer sleep study cohort in history.

About S+ by ResMed

For more information about the S+ by ResMed technology, refer to this fact sheet.

About the SleepScore Campaign

For more information on the “One Million Nights” campaign to find out America’s SleepScore, visit www.sleepscore.com.

About SleepScore Labs

SleepScore Labs is a new company formed by Dr. Mehmet Oz, Pegasus Capital Advisors, L.P, and ResMed (NYSE: RMD) to measure, monitor and ultimately help solve the world’s sleep problems. Today, over 60% of adults in America and around the world have problems with poor sleep due to conditions like snoring, sleep apnea, insomnia, restless leg syndrome, pain, discomfort, and lifestyle choices. SleepScore Labs was created to address these issues through data collected by SleepScore by ResMed technology, the world’s first non-contact, personalized sleep solution to measure an individual’s sleep quality and deliver personalized feedback that helps improve sleep from the very first night. As part of the new venture, ResMed’s SleepScore technology will be available for licensing in new sleep products and will be used by product manufacturers to develop better sleep solutions for consumers. The technology has been licensed to several global leaders and is being used by companies, including Lighting Science Group, in studies to establish the effectiveness of consumer sleep products.

For more information on the campaign, please visit www.sleepscore.com. For more information on SleepScore Labs visit www.sleepscorelabs.com.

EN
06/01/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ResMed Inc.

 PRESS RELEASE

Resmed Announces Participation in the 44th Annual J.P. Morgan Healthca...

Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, beginning at approximately 10:30 a.m. (Pacific Standard Time) in San Francisco, CA. More information about this event, including access to the live, audio-only webcast, may be accessed by visiting . The audio-only webcast replay...

 PRESS RELEASE

Resmed Receives FDA Clearance for Personalized Therapy Comfort Setting...

Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy Technology uses real-world sleep data and machine learning to help people with sleep apnea start and stay on therapy  SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has received U.S. Food and Drug Administration (FDA) clearance for Personalized Therapy Comfort Setting...

ResMed Inc: 1 director

A director at ResMed Inc sold/sold after exercising options 2,055 shares at 255.000USD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over t...

 PRESS RELEASE

Resmed Inc. Announces Results for the First Quarter of Fiscal Year 202...

Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026 Revenue increased by 9% to $1.3 billion; up 8% on a constant currency basis Gross margin up 290 bps to 61.5%; non-GAAP gross margin up 280 bps to 62.0%Income from operations increased 15%; non-GAAP income from operations up 19%Diluted earnings per share of $2.37; non-GAAP diluted earnings per share of $2.55Operating cash flow of $457 million Note: A webcast of Resmed’s conference call will be available at 4:30 p.m. ET today at  SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Resmed Inc. (NYSE: RMD, ASX: RMD) to...

 PRESS RELEASE

Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 202...

Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025 SAN DIEGO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2026 on Thursday, October 30, 2025, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details:  •Location: •Date:Thursday, October 30, 2025 •Time:1:30 p.m. PD...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch